Avidity Biosciences (RNA) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to -$1.27.
- Avidity Biosciences' EPS (Weighted Average and Diluted) fell 9538.46% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.19, marking a year-over-year decrease of 4498.27%. This contributed to the annual value of -$2.89 for FY2024, which is 81.6% up from last year.
- Per Avidity Biosciences' latest filing, its EPS (Weighted Average and Diluted) stood at -$1.27 for Q3 2025, which was down 9538.46% from -$1.21 recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' EPS (Weighted Average and Diluted) ranged from a high of -$0.65 in Q2 2024 and a low of -$1.27 during Q3 2025
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.8 (2023), whereas its average is -$0.83.
- As far as peak fluctuations go, Avidity Biosciences' EPS (Weighted Average and Diluted) skyrocketed by 2826.09% in 2023, and later tumbled by 9538.46% in 2025.
- Avidity Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.84 in 2021, then dropped by 5.95% to -$0.89 in 2022, then grew by 10.11% to -$0.8 in 2023, then fell by 14.78% to -$0.92 in 2024, then crashed by 38.31% to -$1.27 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.27 for Q3 2025, versus -$1.21 for Q2 2025 and -$0.9 for Q1 2025.